• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促黄体生成激素释放激素拮抗剂的构效关系研究,重点关注氨基末端区域。

Structure-activity studies of antagonists of luteinizing hormone-releasing hormone with emphasis on the amino-terminal region.

作者信息

Hocart S J, Nekola M V, Coy D H

出版信息

J Med Chem. 1987 Apr;30(4):735-9. doi: 10.1021/jm00387a029.

DOI:10.1021/jm00387a029
PMID:3550087
Abstract

The structure-activity relationship of the hydrophobic amino terminal region of the antagonist [N-Ac-D-Nal1,D-pClPhe2,D-Trp3,D-Arg6,Phe7,D-Ala10]-LH- RH has been investigated by the incorporation of a variety of amino acids with emphasis on positions 1, 2, and 3. The analogues were prepared by routine solid-phase peptide synthesis. All purifications were performed in two stages: gel permeation chromatography followed by preparative, reversed-phase, high-performance chromatography. The analogues were assayed in a standard rat antiovulatory assay using a 40% propane-1,2-diol-saline vehicle. A simplified antagonist was developed that allowed the removal of the custom-synthesized D-pClPhe and the labile D-Trp while retaining antiovulatory potency. The compound [N-Ac-D-Nal1,D-Phe2,3,D-Arg6,Phe7,D-Ala10]-LH-RH caused a 56% blockade of ovulation at the 500-ng dose and is approximately equipotent with the parent analogue in this system.

摘要

通过引入多种氨基酸,重点研究拮抗剂[N-乙酰基-D-萘丙氨酸1,D-对氯苯丙氨酸2,D-色氨酸3,D-精氨酸6,苯丙氨酸7,D-丙氨酸10]-促性腺激素释放激素疏水氨基末端区域的构效关系,重点关注第1、2和3位。类似物通过常规固相肽合成制备。所有纯化均分两个阶段进行:凝胶渗透色谱,然后是制备型反相高效色谱。类似物在标准大鼠抗排卵试验中使用40%丙二醇-盐水载体进行测定。开发了一种简化的拮抗剂,可去除定制合成的D-对氯苯丙氨酸和不稳定的D-色氨酸,同时保留抗排卵效力。化合物[N-乙酰基-D-萘丙氨酸1,D-苯丙氨酸2,3,D-精氨酸6,苯丙氨酸7,D-丙氨酸10]-促性腺激素释放激素在500 ng剂量时引起56%的排卵阻断,在该系统中与母体类似物大致等效。

相似文献

1
Structure-activity studies of antagonists of luteinizing hormone-releasing hormone with emphasis on the amino-terminal region.促黄体生成激素释放激素拮抗剂的构效关系研究,重点关注氨基末端区域。
J Med Chem. 1987 Apr;30(4):735-9. doi: 10.1021/jm00387a029.
2
Improved antagonists of luteinizing hormone-releasing hormone modified in position 7.在第7位进行修饰的促黄体生成激素释放激素的改良拮抗剂。
J Med Chem. 1985 Jul;28(7):967-70. doi: 10.1021/jm00145a022.
3
Effect of reductive alkylation of D-lysine in position 6 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists.6位D-赖氨酸的还原烷基化对促黄体生成激素释放激素拮抗剂组胺释放活性的影响
J Med Chem. 1987 Apr;30(4):739-43. doi: 10.1021/jm00387a030.
4
Effect of the CH2NH and CH2NAc peptide bond isosteres on the antagonistic and histamine releasing activities of a luteinizing hormone-releasing hormone analogue.
J Med Chem. 1988 Sep;31(9):1820-4. doi: 10.1021/jm00117a024.
5
Effect of reductive alkylation of lysine in positions 6 and/or 8 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists.赖氨酸6位和/或8位的还原烷基化对促黄体生成素释放激素拮抗剂组胺释放活性的影响。
J Med Chem. 1987 Oct;30(10):1910-4. doi: 10.1021/jm00393a038.
6
Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6.
Biochem Biophys Res Commun. 1986 Jun 13;137(2):709-15. doi: 10.1016/0006-291x(86)91136-8.
7
Synthesis and biological activity of LH-RH antagonists modified in position 1.
Peptides. 1982 Nov-Dec;3(6):969-71. doi: 10.1016/0196-9781(82)90066-3.
8
Structural requirements in positions 1, 2, 3, and 6 of the luteinizing hormone-releasing hormone (LH-RH) for antiovulatory activity.促黄体生成激素释放激素(LH-RH)第1、2、3和6位上抗排卵活性的结构要求。
J Med Chem. 1979 Jul;22(7):774-7. doi: 10.1021/jm00193a005.
9
Relative potencies of antagonists of the luteinizing hormone releasing hormone with Lys8 and Arg8 and substitutions in positions 3, 5, 6, 7 and 8.具有赖氨酸8和精氨酸8以及3、5、6、7和8位取代的促黄体生成素释放激素拮抗剂的相对效价
Z Naturforsch C J Biosci. 1986 Nov-Dec;41(11-12):1087-91.
10
Luteinizing hormone-releasing hormone antagonists containing very hydrophobic amino acids.
J Med Chem. 1984 Sep;27(9):1170-4. doi: 10.1021/jm00375a015.